The Drug Controller General of India has approved pharmaceutical firm Zydus Cadila to start Phase I and Phase II human clinical trials of its COVID-19 vaccine. This is the second vaccine after...
from NDTV News - Special https://ift.tt/3dVhcAD
Subscribe to:
Post Comments (Atom)
In FY26, NTPC consolidated profit rises 15%
from Business News Today: Stock Markets, Financial News, India Business & World Business News https://ift.tt/kM9eUzX
-
China has emerged as a significant player in AI foundation models with DeepSeek, creating powerful AI models at lower costs than the West. T...
-
Nigeria's President Buhari on Sunday denied claims that he had died and been replaced by a Sudanese impostor, breaking his silence on a ...
-
Meng Wanzhou, the high-profile top executive of telecom giant Huawei who was detained in Canada for over three years, received a hero's ...
No comments:
Post a Comment